<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>35(5)</volume><submitter>Vandecaveye V</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Diagnostic imaging of peritoneal metastases in ovarian and colorectal cancer remains pivotal in selecting the most appropriate treatment and balancing clinical benefit with treatment-related morbidity and mortality. To address the challenges related to diagnostic imaging and detecting and reporting peritoneal metastatic spread, a joint guideline was created by the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Society of Urogenital Radiology (ESUR), Peritoneal Surface Oncology Group International (PSOGI), and European Association of Nuclear Medicine (EANM).&lt;h4>Methods&lt;/h4>A targeted literature search was performed and consensus recommendations were proposed using Delphi questionnaires and a five-point Likert scale.&lt;h4>Results&lt;/h4>A total o</pubmed_abstract><journal>European radiology</journal><pagination>2712-2722</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12021955</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM.</pubmed_title><pmcid>PMC12021955</pmcid><pubmed_authors>European Society of Gastrointestinal and Abdominal Radiology (ESGAR)</pubmed_authors><pubmed_authors>Nikolic O</pubmed_authors><pubmed_authors>Lahaye MJ</pubmed_authors><pubmed_authors>Vandecaveye V</pubmed_authors><pubmed_authors>European Association of Nuclear Medicine (EANM)</pubmed_authors><pubmed_authors>Peritoneal Surface Oncology Group International (PSOGI)</pubmed_authors><pubmed_authors>Nougaret S</pubmed_authors><pubmed_authors>Hameed M</pubmed_authors><pubmed_authors>Stepanyan A</pubmed_authors><pubmed_authors>Otero-Garcia M</pubmed_authors><pubmed_authors>de Hingh IHJ</pubmed_authors><pubmed_authors>Goffin K</pubmed_authors><pubmed_authors>Rousset P</pubmed_authors><pubmed_authors>European Society of Urogenital Radiology (ESUR)</pubmed_authors></additional><is_claimable>false</is_claimable><name>Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM.</name><description>&lt;h4>Objectives&lt;/h4>Diagnostic imaging of peritoneal metastases in ovarian and colorectal cancer remains pivotal in selecting the most appropriate treatment and balancing clinical benefit with treatment-related morbidity and mortality. To address the challenges related to diagnostic imaging and detecting and reporting peritoneal metastatic spread, a joint guideline was created by the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Society of Urogenital Radiology (ESUR), Peritoneal Surface Oncology Group International (PSOGI), and European Association of Nuclear Medicine (EANM).&lt;h4>Methods&lt;/h4>A targeted literature search was performed and consensus recommendations were proposed using Delphi questionnaires and a five-point Likert scale.&lt;h4>Results&lt;/h4>A total o</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2025-07-01T03:05:33.625Z</modification><creation>2025-07-01T03:05:33.625Z</creation></dates><accession>S-EPMC12021955</accession><cross_references><pubmed>39499302</pubmed><doi>10.1007/s00330-024-11124-5</doi></cross_references></HashMap>